NM_014714.4:c.*430G>A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_014714.4(IFT140):​c.*430G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 244,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000032 ( 0 hom. )

Consequence

IFT140
NM_014714.4 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.13

Publications

0 publications found
Variant links:
Genes affected
IFT140 (HGNC:29077): (intraflagellar transport 140) This gene encodes one of the subunits of the intraflagellar transport (IFT) complex A. Intraflagellar transport is involved in the genesis, resorption and signaling of primary cilia. The primary cilium is a microtubule-based sensory organelle at the surface of most quiescent mammalian cells, that receives signals from its environment, such as the flow of fluid, light or odors, and transduces those signals to the nucleus. Loss of the corresponding protein in mouse results in renal cystic disease. [provided by RefSeq, Jun 2012]
TELO2 (HGNC:29099): (telomere maintenance 2) This gene encodes a protein that functions as an S-phase checkpoint protein in the cell cycle. The protein may also play a role in DNA repair.[provided by RefSeq, Mar 2009]
TELO2 Gene-Disease associations (from GenCC):
  • TELO2-related intellectual disability-neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014714.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFT140
NM_014714.4
MANE Select
c.*430G>A
3_prime_UTR
Exon 31 of 31NP_055529.2
TELO2
NM_016111.4
MANE Select
c.*578C>T
downstream_gene
N/ANP_057195.2Q9Y4R8
TELO2
NM_001351846.2
c.*578C>T
downstream_gene
N/ANP_001338775.1Q9Y4R8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFT140
ENST00000426508.7
TSL:5 MANE Select
c.*430G>A
3_prime_UTR
Exon 31 of 31ENSP00000406012.2Q96RY7-1
IFT140
ENST00000361339.9
TSL:1
c.*430G>A
3_prime_UTR
Exon 13 of 13ENSP00000354895.5Q96RY7-2
IFT140
ENST00000889170.1
c.*430G>A
3_prime_UTR
Exon 30 of 30ENSP00000559229.1

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152150
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD4 exome
AF:
0.0000324
AC:
3
AN:
92526
Hom.:
0
Cov.:
0
AF XY:
0.0000407
AC XY:
2
AN XY:
49090
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
1556
American (AMR)
AF:
0.00
AC:
0
AN:
4052
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2398
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2560
South Asian (SAS)
AF:
0.00
AC:
0
AN:
14828
European-Finnish (FIN)
AF:
0.000645
AC:
3
AN:
4648
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
402
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
57070
Other (OTH)
AF:
0.00
AC:
0
AN:
5012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.642
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0000919
AC:
14
AN:
152268
Hom.:
0
Cov.:
33
AF XY:
0.000107
AC XY:
8
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41552
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67996
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.0000869
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Saldino-Mainzer syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.0
DANN
Benign
0.55
PhyloP100
-1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs532233762; hg19: chr16-1560515; API